Rotech Healthcare Inc. announced that it has won an $88.27 million federal contract from the U.S. Department of Veterans Affairs Medical Center, Phoenix, for medical and home health oxygen equipment.

Rotech Healthcare Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2009. For the quarter, the company reported that total net revenues were $122.5 million as compared to $132.8 million for the comparable period in 2008. This decrease of $10.3 million from the comparable period in 2008 is primarily attributable to a $7.0 million impact of the 36-month oxygen cap, a $4.5 million impact of the 9.5% MIPAA reduction, and a $10.7 million impact of reductions in nebulizer medication reimbursement and volume. These decreases were partially offset by organic growth in CPAP supply revenue which increased $8.2 million for the three months ended September 30, 2009 from the comparable period in 2008, approximately $4.0 million of gross revenues associated with patients transitioned onto service with company through equipment purchases and lower revenue adjustments as a result of improved overall collection experience and increased accuracy in initial recognition of net allowable amounts from payors. Net loss was $4.5 million compared to a net loss of $217.6 million for the comparable period in 2008. This $213.1 million decrease in net loss is primarily attributable to the $207.0 million non-cash goodwill impairment charge and the aforementioned restructuring initiatives. The company reported operating income of $6.41 million, loss before income taxes of $4.81 million and net loss attributable to common stockholders of $4.65 million or $0.18 per diluted share compared to operating loss of $205.99 million, loss before income taxes of $217.91 million and net loss attributable to common stockholders of $217.76 million or $8.54 per diluted share for the same period a year ago. For the nine months, total net revenues were $356.7 million as compared to $415.5 million for the comparable period in 2008. This decrease of $58.9 million from the comparable period in 2008 is primarily attributable to a $19.9 million impact of the 36-month oxygen cap, a $13.2 million impact of the 9.5% MIPAA reduction, and a $47.1 million impact of reductions in nebulizer medication reimbursement and volume. These decreases were primarily offset by organic growth in CPAP supply revenue which increased $20.6 million for the nine months ended September 30, 2009 from the comparable period in 2008 and approximately $4.0 million of gross revenues associated with patients transitioned onto service with company through equipment purchases. Net loss was $16.4 million compared to a net loss of $241.7 million for the nine months ended September 30, 2008. This $225.3 million decrease in net loss is primarily attributable to the $207.0 million non-cash goodwill impairment charge and the aforementioned restructuring initiatives. The company reported operating income of $16.35 million, loss before income taxes of $16.40 million and net loss attributable to common stockholders of $16.73 million or $0.66 per diluted share compared to operating loss of $205.71 million, loss before income taxes of $242.24 million and net loss attributable to common stockholders of $16.73 million or $9.49 per diluted share for the same period a year ago. Net cash provided by operating activities was $40.8 million as compared to $52.2 million for the same period in 2008. Capital expenditures totaled approximately $31.7 million as compared to $37.6 million for the same period in 2008. The decrease in 2009 capital expenditures is primarily attributable to improved equipment maintenance programs and increased management controls. Included in the $31.7 million of capital expenditures for the nine months ended September 30, 2009 is $9.4 million paid for new and used rental equipment from competitors exiting the home health care market. Most of the equipment purchased in these transactions is currently on rent and located in a patient's home.

Rotech Healthcare Inc. reported earnings results for the first quarter ended March 31, 2009. For the quarter, the company reported net loss of $6.48 million. In contrast, the company reported net loss of $13.95 million for the same quarter in the previous year.

ROTECH HEALTHCARE INC Files SEC form 10-K, Annual Report

ROTECH HEALTHCARE INC Files SEC form 8-K, Change in Directors or Principal Officers

ROTECH HEALTHCARE INC Files SEC form 10-Q, Quarterly Report

ROTECH HEALTHCARE INC Files SEC form 10-Q, Quarterly Report

ROTECH HEALTHCARE INC Files SEC form 10-Q, Quarterly Report

ROTECH HEALTHCARE INC Files SEC form 8-K, Other Events

ROTECH HEALTHCARE INC Files SEC form 8-K, Other Events